• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可移动和不可移动小分子抑制剂对钙磷病理性矿化的调节机制。

Mechanisms of Modulation of Calcium Phosphate Pathological Mineralization by Mobile and Immobile Small-Molecule Inhibitors.

机构信息

College of Resources and Environment, Huazhong Agricultural University , Wuhan 430070, China.

College of Chemistry and Molecular Sciences, Wuhan University , Wuhan 430072, China.

出版信息

J Phys Chem B. 2018 Feb 8;122(5):1580-1587. doi: 10.1021/acs.jpcb.7b10956. Epub 2018 Jan 27.

DOI:10.1021/acs.jpcb.7b10956
PMID:29346735
Abstract

Potential pathways for inhibiting crystal growth are via either disrupting local microenvironments surrounding crystal-solution interfaces or physically blocking solute molecule attachment. However, the actual mode of inhibition may be more complicated due to the characteristic time scale for the inhibitor adsorption and relaxation to a well-bound state at crystal surfaces. Here we demonstrate the role of citrate (CA) and hydroxycitrate (HCA) in brushite (DCPD, CaHPO·2HO) crystallization over a broad range of both inhibitor concentrations and supersaturations by in situ atomic force microscopy (AFM). We observed that both inhibitors exhibit two distinct actions: control of surface crystallization by the decrease of step density at high supersaturations and the decrease of the [1̅00] step velocity at high inhibitor concentration and low supersaturation. The switching of the two distinct modes depends on the terrace lifetime, and the slow kinetics along the [1̅00] step direction provides specific sites for the newly formed dislocations. Molecular modeling shows the strong HCA-crystal interaction by molecular recognition, explaining the AFM observations for the formation of new steps and surface dissolution along the [101] direction due to the introduction of strong localized strain in the crystal lattice. These direct observations highlight the importance of the inhibitor coverage on mineral surfaces, as well as the solution supersaturation in predicting the inhibition efficacy, and reveal an improved understanding of inhibition of calcium phosphate biomineralization, with clinical implications for the full therapeutic potential of small-molecule inhibitors for kidney stone disease.

摘要

抑制晶体生长的潜在途径是通过破坏晶体-溶液界面周围的局部微环境或物理阻挡溶质分子附着。然而,由于抑制剂在晶体表面上吸附和解离到稳定状态的特征时间尺度,实际的抑制模式可能更为复杂。在这里,我们通过原位原子力显微镜(AFM)在广泛的抑制剂浓度和过饱和度范围内,展示了柠檬酸盐(CA)和羟基柠檬酸(HCA)在磷酸氢钙(DCPD,CaHPO·2HO)结晶中的作用。我们观察到两种抑制剂都表现出两种不同的作用:通过降低高过饱和度下的台阶密度来控制表面结晶,以及在高抑制剂浓度和低过饱和度下降低[1̅00]台阶速度。两种不同模式的切换取决于平台寿命,而沿[1̅00]台阶方向的缓慢动力学为新形成的位错提供了特定的位置。分子建模通过分子识别显示了 HCA 与晶体的强相互作用,解释了 AFM 观察到的新台阶形成和沿[101]方向的表面溶解现象,这是由于晶格中引入了强烈的局部应变。这些直接观察结果强调了抑制剂在矿物表面上的覆盖率以及溶液过饱和度在预测抑制效果方面的重要性,并揭示了对钙磷酸盐生物矿化抑制的更深入理解,这对小分子抑制剂在肾结石疾病中的全面治疗潜力具有临床意义。

相似文献

1
Mechanisms of Modulation of Calcium Phosphate Pathological Mineralization by Mobile and Immobile Small-Molecule Inhibitors.可移动和不可移动小分子抑制剂对钙磷病理性矿化的调节机制。
J Phys Chem B. 2018 Feb 8;122(5):1580-1587. doi: 10.1021/acs.jpcb.7b10956. Epub 2018 Jan 27.
2
Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.分子修饰物揭示了病理性晶体生长抑制的机制。
Nature. 2016 Aug 25;536(7617):446-50. doi: 10.1038/nature19062. Epub 2016 Aug 17.
3
Molecular modulation of calcium oxalate crystallization.草酸钙结晶的分子调控
Am J Physiol Renal Physiol. 2006 Dec;291(6):F1123-31. doi: 10.1152/ajprenal.00136.2006.
4
Direct imaging of nanoscale dissolution of dicalcium phosphate dihydrate by an organic ligand: concentration matters.直接成像观察二水磷酸氢钙的纳米级溶解过程:浓度是关键。
Environ Sci Technol. 2013;47(23):13365-74. doi: 10.1021/es402748t. Epub 2013 Nov 19.
5
Underlying Role of Brushite in Pathological Mineralization of Hydroxyapatite.在羟基磷灰石病理性矿化中的水合磷酸钙的潜在作用。
J Phys Chem B. 2019 Apr 4;123(13):2874-2881. doi: 10.1021/acs.jpcb.9b00728. Epub 2019 Mar 14.
6
Inhibition of Spiral Growth and Dissolution at the Brushite (010) Interface by Chondroitin 4-Sulfate.硫酸软骨素 4 硫酸盐抑制 Brushite(010)界面的螺旋生长和溶解。
J Phys Chem B. 2019 Jan 31;123(4):845-851. doi: 10.1021/acs.jpcb.8b11531. Epub 2019 Jan 17.
7
Subnanometer atomic force microscopy of peptide-mineral interactions links clustering and competition to acceleration and catastrophe.肽-矿物相互作用的亚纳米原子力显微镜研究将聚类和竞争与加速和突发联系起来。
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):11-5. doi: 10.1073/pnas.0908205107. Epub 2009 Dec 14.
8
Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.骨桥蛋白和柠檬酸盐对草酸钙结晶的分子调节作用
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1811-5. doi: 10.1073/pnas.0307900100. Epub 2004 Feb 6.
9
Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.透钙磷石晶体在草酸钙结晶中的双重作用为肾结石形成提供了物理化学机制。
Kidney Int. 2006 Jul;70(1):71-8. doi: 10.1038/sj.ki.5000424. Epub 2006 Apr 26.
10
Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps.柠檬酸盐通过选择性结合原子台阶对一水合草酸钙结晶的调控
J Am Chem Soc. 2005 Jun 29;127(25):9036-44. doi: 10.1021/ja043591s.

引用本文的文献

1
The effect of chemical structure of carboxylate molecules on hydroxyapatite nanoparticles. A structural and morphological study.羧酸盐分子化学结构对羟基磷灰石纳米颗粒的影响。一项结构与形态学研究。
Bioact Mater. 2021 Jan 26;6(8):2360-2371. doi: 10.1016/j.bioactmat.2021.01.010. eCollection 2021 Aug.
2
Phosphoserine Functionalized Cements Preserve Metastable Phases, and Reprecipitate Octacalcium Phosphate, Hydroxyapatite, Dicalcium Phosphate, and Amorphous Calcium Phosphate, during Degradation, In Vitro.磷酸丝氨酸功能化骨水泥在体外降解过程中能保留亚稳相,并使磷酸八钙、羟基磷灰石、磷酸二钙和无定形磷酸钙再沉淀。
J Funct Biomater. 2019 Nov 27;10(4):54. doi: 10.3390/jfb10040054.
3
Hydroxycitrate: a potential new therapy for calcium urolithiasis.
羟基柠檬酸:治疗钙结石的一种潜在新疗法。
Urolithiasis. 2019 Aug;47(4):311-320. doi: 10.1007/s00240-019-01125-1. Epub 2019 Mar 26.